Once you decide you would like to work with Tempus, contact us at firstname.lastname@example.org and we will send you appropriate manuals, forms and specimen collection kits based on your specific needs and requirements.
A test can be ordered by faxing a completed requisition form to us at 708.575.1789.
Our labs sequence both DNA and RNA from tumor samples as well as matched DNA from normal samples. Sequencing options include a targeted panel of 596 genes (at 500x coverage), an onco-seq panel of 1714 genes (at 500x coverage), whole exome (at 150x coverage) and whole genome (at 30x coverage).
Yes, the lab is CLIA-certified and CAP-accredited.
Tempus requires your patient’s tumor and blood or saliva specimens for DNA and RNA extraction and amplification. Tissue specimen handling and preparation procedures should meet our requirements, which are available here. Tempus handles obtaining the tumor specimen.
Somatic sequencing using formalin-fixed or fresh-frozen samples to identify genomic aberrations in cancer malignancies. All sequencing data will be available for analysis, and all potentially relevant therapies are reported and prioritized based on the strength of the clinical evidence that establishes the association between a given genomic alteration and a relevant therapeutic option.
RNA sequencing using tumor samples to analyze actionable genomic aberrations (e.g. gene fusions), gene expression analysis, rare and novel transcript discovery, and splice variant detection.
Tempus reports on all relevant therapeutic indications for detected somatic or gene expression alterations for which there is clinical evidence linking a given alteration to any FDA approved therapy in the cancer under study, or another cancer, and for alterations associated with a known or suspected contraindication to a given therapy. The first page summarizes the most relevant therapies with potential benefit and potential lack of benefit. Relevant therapies are prioritized based on the strength of the clinical evidence that establishes the association between a given genomic alteration and a relevant therapeutic option. The report cites all of the references for the clinical evidence that establishes the association between each genomic alteration and its matching therapy and additionally provides a complete bibliography of published research relevant to the targeted biomarkers and therapies. The clinical trials section matches your patient to eligible biomarker-based clinical trials.
Tempus uses capture RNA-seq to assess gene rearrangements and RNA expression levels from clinical FFPE tissue samples.
This method is based on techniques published by Tempus scientific advisor Arul Chinnaiyan: “Through validation against gold-standard poly(A) and Ribo-Zero libraries from intact RNA, we show that capture RNA-seq provides accurate and unbiased estimates of RNA abundance, uniform transcript coverage, and broad dynamic range. Unlike poly(A) selection and Ribo-Zero depletion, capture libraries retain these qualities regardless of RNA quality and provide excellent data from clinical specimens including formalin-fixed paraffin-embedded (FFPE) blocks.”
A PDF of the summary section of the report will be emailed to you. In addition, when your first Tempus report is complete, you will receive an email with your unique login information. Once the report is complete, you will be able to login to access your patientʼs detailed report, including both the clinical and research sections.
Tempus sequencing results are returned within approximately two to three weeks of receipt of samples (both blood and tissue). Sequencing will not begin until all required specimens are received.
Yes, we work with many academic institutions and principal investigators on research projects pertaining to genomic sequencing of cancer patients. Please email email@example.com to get started.
Please call our Customer Support Team at 800.739.4137 or email firstname.lastname@example.org.
No. Tempus can only be ordered by your physician.
Knowing the alterations that are driving your cancer may help to identify targeted FDA-approved and clinical trial therapies that in some cases have been proven to be more effective than organ- and tissue-specific treatments.
Your doctor will need to order the test directly from Tempus by completing a simple requisition form. We will coordinate the collection of specimen samples (blood or saliva, as necessary) and will request the tumor sample from your hospital’s pathology department
From the time Tempus receives the necessary specimen samples, it typically takes approximately two to three weeks to sequence and generate your report. The report will be delivered to your physician, who will contact you when the results are received.
We will work with your insurance company to submit for reimbursement. A comprehensive patient-assistance program is also available. Visit access.tempus.com or download our patient financial assistance form here.
We will work with your hospitalʼs pathology department to obtain your tissue sample. Your tumor sample will be sent to our secure sequencing lab in Chicago.
We generate a comprehensive report that will present your tumor biology, potential targeted therapies and your patient history. The report will also highlight recruiting clinical trials, if available, that fit your profile. We also provide other insights for deeper exploration of available options.
The report will be sent to your physician to share with you.
Our services explore options for patients with metastatic, refractory and recurrent cancer. Eligible patients include those with cancer of unknown origin; rare or uncommon solid tumors with limited treatment options; solid tumors not responding to standard of care; recurrent or metastatic cancer, or an interest in enrolling in clinical trials. It’s up to your doctor to decide if genetic sequencing can help in your cancer treatment.
Our comprehensive approach checks hundreds of genes for alterations by testing both the tumor tissue DNA and the normal tissue DNA along with testing the RNA. By testing all three together, we improve the detection of tumor-specific alterations and take a deep look into your tumor’s biology.
Tempus accepts all insurance plans; however, at this time, we are not an in-network provider.
Nothing. An Explanation of Benefits (EOB) is not a bill; it is a communication from your insurance company regarding the Tempus services you received. It shows services that were billed to insurance and what insurance covered. An EOB may not require payment even if there is an amount due for patient responsibility.
If coverage is denied, Tempus will file appeal(s) with your insurance company to pursue coverage on your behalf. We may contact you or your physician for assistance during the appeals process as needed.
Tempus will send a bill to you for the amount paid to you once we are notified by your insurance company. You may pay the bill to Tempus directly or endorse the check from your insurance company to Tempus by signing the back of the check on the top line of the endorsement area, and writing “pay to the order of Tempus Labs” on the second line.
Yes, Tempus has established a patient access program to make certain all who need testing have access to our tests and that the cost does not create undue financial hardship. Approval for financial assistance is determined by household income, extenuating circumstances, and U.S.-based residency.
Through our program, eligible patients may reduce their total financial responsibility to anywhere between $0-$100. Assistance applies towards out-of-pocket costs such as copays, coinsurance, deductibles, or their self pay balance. Patients are not responsible for non-covered services, also known as balance billing. In the event that you don’t qualify and could owe more than $100, we will contact you to discuss your options.
We encourage all patients to apply for financial assistance at the time of order, but applications are accepted at any point during the order/billing process. Applications are available at access.tempus.com.
If unable to complete the online or paper application, please contact our Client Services team at 800-739-4137 for assistance.
Online Applicants: We encourage patients to fill out the online form to expedite notification of application status, many patients are awarded coverage at the time of submission. Online applicants with a ‘pending’ status will be contacted within 2 business days of submission.
Fax / Email Applicants: Notification within 5 business days of receipt.
Tempus is committed to providing access for patients without insurance and or those that choose to pay for services directly. We encourage domestic patients to apply for financial assistance to see if you are eligible for additional discounts.
Self pay forms are available for both domestic and international patients. Payment must be made prior to testing. The test will be cancelled if Tempus doesn’t receive payment within 30 days from time of order.
Our Client Services Team is available from 9:00 am CT – 5:00 pm CT, Monday through Friday at 800-739-4137 or email at email@example.com
Your credentials (your email and a temporary password) will be emailed at the time of placing your first order. You will be prompted to set a permanent password when you log in for the first time. Please go to clinical-portal.securetempus.com to log in.
Navigate to clinical-portal.securetempus.com and click on the “Forgot Password” button. A temporary password will be sent to your email account. You will then be prompted to create a new unique password.
Please check that you are using our minimum browser requirements (listed in order of preference): Chrome, IE 11, Firefox, Safari. Tempus portal performs best when using Chrome.
This is likely to be due to your institutionʼs IT setup. Please contact your IT staff and request that they whitelist *.securetempus.com. You should request they whitelist the entire domain, so that images and static texts from different subdomains will load. Alternatively, Tempus will gladly work with your IT on troubleshooting setup. Please email us at firstname.lastname@example.org with contact information.
Please refresh your browser. If the pdf continues to fail to render, email email@example.com with the patient name.
Please try the patientʼs first name last name, or MRN. The name is not case sensitive. If the record does not load within one minute, please email us at firstname.lastname@example.org
We are always working to improve the search functionality, but it can take up to 1-2 minutes to load the initial portal. If it takes longer than three minutes, please try reloading. If you donʼt have specific patients assigned to you, please try searching the patient name as it may not always show up in the portal.
You can navigate to historic orders and reports by searching by patient name or MRN in the top search bar.